Becton, Dickinson and Company
https://www.bd.com/en-us
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Becton, Dickinson and Company
Why US Payers Aren’t Reimbursing Obesity Meds
Payers are restricting access to obesity drugs due to huge patient numbers and a wave of innovation in other areas
Lilly Adds To Radiopharma Arsenal With Option To Buy Radionetics
Lilly paid $140m up front for an option to acquire Radionetics for $1bn within an undisclosed timeframe. The private firm is developing small molecule GPCR-targeted radiopharmaceuticals.
Wave Chasing Huntington’s Accelerated Approval Based On Caudate Atrophy Surrogate
The biotech plans a pivotal trial that would support accelerated approval of the Takeda-partnered antisense oligonucleotide, WVE-003, and will discuss it with regulators before the end of the year.
Poland’s Quiet Pivot From Generics To Innovative Treatments
Poland is slowly expanding beyond its position as a central European generics hub. More established companies are adding innovative medicine pipelines and a small number of biotechs are making international deals.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
- Drug Delivery
-
Medical Devices
- Diagnostic Equipment & Supplies
- Implantable Devices
-
Biotechnology
- Drug Discovery Tools
- Other Names / Subsidiaries
-
- BD
- BD Medical
- Bridger Biomed, Inc.
- Caesarea Medical Electronics
- CareFusion
- Carmel Pharma, Inc.
- Carmel Pharma, AB
- Cellular Research, Inc.
- C.R. Bard, Inc.
- CRISI Medical Systems
- Davol, Inc.
- Embo Medical Limited
- FlowCardia, Inc.
- GenCell Biosystems, Ltd.
- GeneOhm Sciences
- Liberator Medical, Inc.
- Lutonix, Inc.
- Medafor, Inc.
- Medicon, Inc.
- Neomend, Inc.
- Sirigen Group Limited
- TriPath Imaging
- TVA Medical, Inc.
- Rochester Medical, Inc.
- Safety Syringes Inc.
- Vascular Pathways, Inc.
- Venclose, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice